Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
SAGE documentation
GRADE table
Clear all
Type of publications
SAGE documentation
(66)
Topics
GRADE table
(66)
Available to download in languages
English (EN)
(66)
Regions
Countries
Diseases
Cholera
(1)
COVID-19
(2)
Dengue
(6)
Diphtheria
(1)
Haemophilus influenzae type B
(3)
Hepatitis A
(6)
Human papillomavirus (HPV)
(9)
Influenza
(11)
Japanese encephalitis
(9)
Measles
(6)
Meningococcal disease
(4)
Pertussis
(2)
Rubella
(1)
Typhoid
(2)
Vaccine topics
Target population
Publication date
66 results found
2024
∙
SAGE
Dengue Vaccine (TAK-003) GRADE tables
2022
∙
SAGE
Annexes to the 2022 WHO Hepatitis A Vaccine Position Paper
2022
∙
SAGE
Should an off-label , permissive one-dose HPV vaccine schedule for use in routine and/or multi-age cohort (MAC) catch up strategies be recommended?
2022
∙
SAGE
Annexes to the interim recommendations for use of the Bharat Biotech BBV152 COVAXIN® vaccine against COVID-19
2022
∙
SAGE
Annexes to the interim recommendations for use of the Cansino Ad5-nCoV-S vaccine (Convidecia ®) against COVID-19
2020
∙
SAGE
Grading tables for assessment of scientific evidence on rubella vaccines
2018
∙
SAGE
What is the efficacy of 3 doses of CYD-TDV in preventing clinical dengue in seronegative individuals 9-16 years of age in the first year following vaccination?
2018
∙
SAGE
What is the efficacy of 3 doses of CYD-TDV in preventing clinical dengue in seropositive individuals 9-16 years of age in the first year following vaccination?
2018
∙
SAGE
What is the duration of protection/risk in seropositive individuals 9-16 years of age vaccinated with CYD-TDV?
2018
∙
SAGE
What is the duration of protection/risk in seronegative individuals 9-16 years of age vaccinated with CYD-TDV?
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register